Mutations in BRCA2—a gene known to repair damaged DNA and suppress tumor formation—can predict an individual's predisposition ...

Gene therapy, with its offer of a possible cure for rare diseases like sickle cell, is losing early investors to ...

A new study published in The Lancet Haematology journal says that an indigenously developed gene therapy for certain blood ...

The data pertains to the company’s lead drug candidate, Reqorsa® Gene Therapy, for the treatment of KRASG12C mutant non-small cell lung cancer (NSCLC) resistant to Ras inhibitors. The study ...

Leveraging the power of AI and machine learning technologies, researchers at Weill Cornell Medicine developed a more ...

An indigenously developed CAR T-cell gene therapy has achieved a 73% response rate for certain blood cancers in India. The ...

Evolution in women's cancer diagnostics: from histopathology to molecular testing, personalized treatment for breast, ovarian ...

The study looked at patients with leukaemia, which occurs in bone marrow, and lymphoma, which affects the lymphatic system.

A team of Singapore scientists has made a significant discovery in understanding stomach cancer, a disease that remains one ...

"The clinical trials of India's first gene therapy for cancer offer hopes of another chance to live among these patients, that there is one more drug that doctors can try," lead author Rahul ...

But often the cancer will return and the entire bladder will be removed. “That comes like all kind of the side effects a ...

Bharat Biotech aims to democratize gene therapies, traditionally considered prohibitively expensive and available primarily ...